BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21646742)

  • 21. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.
    Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Quintana-Giner M; Véliz-Martínez A; Orenes-Piñero E; Romero-Aniorte AI; Vicente-Ibarra N; Pernias-Escrig V; Carrillo-Alemán L; Candela-Sánchez E; Hortelano I; Villamía B; Sandín-Rollán M; Nuñez-Martínez L; Valdés M; Marín F
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation and application of estimation of glomerular filtration rate based on serum creatinine and cystatin C in renal function staging].
    Shen ZX; Liu Y; Liu M; Zheng H; Wu XJ; Shen C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1557-1562. PubMed ID: 29141349
    [No Abstract]   [Full Text] [Related]  

  • 26. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.
    Suzuki A; Obi Y; Hayashi T; Kotani N; Uemura Y; Imai E; Makino H; Hishida A
    Clin Exp Nephrol; 2019 May; 23(5):661-668. PubMed ID: 30687876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
    Ridker PM; MacFadyen JG; Glynn RJ; Koenig W; Libby P; Everett BM; Lefkowitz M; Thuren T; Cornel JH
    J Am Coll Cardiol; 2018 May; 71(21):2405-2414. PubMed ID: 29793629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
    Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
    Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
    Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy.
    Ridker PM; Tuttle KR; Perkovic V; Libby P; MacFadyen JG
    Eur Heart J; 2022 Dec; 43(46):4832-4844. PubMed ID: 35943897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
    Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
    Sharma S; Denburg MR; Furth SL
    Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
    Cseprekál O; Egresits J; Tabák Á; Nemcsik J; Járai Z; Babos L; Fodor E; Farkas K; Godina G; Kárpáthi KI; Kerkovits L; Marton A; Nemcsik-Bencze Z; Németh Z; Sallai L; Kiss I; Tislér A
    J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population--Iwate KENCO Study.
    Ohsawa M; Tanno K; Itai K; Turin TC; Okamura T; Ogawa A; Ogasawara K; Fujioka T; Onoda T; Yoshida Y; Omama S; Ishibashi Y; Nakamura M; Makita S; Tanaka F; Kuribayashi T; Koyama T; Sakata K; Okayama A
    Circ J; 2013; 77(5):1315-25. PubMed ID: 23428718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney dysfunction, cardiorespiratory fitness, and the risk of death in women.
    Gulati M; Black HR; Arnsdorf MF; Shaw LJ; Bakris GL
    J Womens Health (Larchmt); 2012 Sep; 21(9):917-24. PubMed ID: 22480201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
    Mielniczuk LM; Pfeffer MA; Lewis EF; Blazing MA; de Lemos JA; Shui A; Mohanavelu S; Califf RM; Braunwald E
    Am Heart J; 2008 Apr; 155(4):725-31. PubMed ID: 18371483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.